cell-free RNA
Flomics Biotech Raises €1.1M for RNA-Based Multicancer Test
The Spanish startup will put the funds toward preclinical validation of its circulating cell-free RNA liquid biopsy.
Lucence Liquid Biopsy Test to Receive Medicare Reimbursement in Lung Cancer
Lucence's amplicon-based LiquidHallmark liquid biopsy assay will now be covered under a finalized local coverage determination from Medicare contractor Palmetto.
Lucence Publishes Clinical Validation of LiquidHallmark Circulating Tumor DNA Test, Expands to RNA
Premium
The firm plans to ramp up US commercialization following the study, while continuing to develop its cell-free RNA diagnostic platform.